Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
A phase II randomized clinical trial was conducted to determine whether etoricoxib could prevent or ameliorate the incidence and/or severity of docetaxel-induced acute pain syndrome. We also aimed to determine if there are any improvement of the late-onset peripheral neuropathy as well as quality of life with prophylactic etoricoxib for breast cancer patients who receive docetaxel chemotherapy.
Epistemonikos ID: 616c0e9653efe2ecced47562b0feaae2c23b8791
First added on: May 07, 2024